Communications between Charlotte Taylor of the Antivirals and therapeutics TaskForce and the CMO

The request was partially successful.

Dear Department of Health and Social Care,

For the period 1 April 2022 to 6 September 2022

All direct communications between Charlotte Taylor of the Antivirals and Therapeutics Taskforce and the Chief Medical Officer in which Evusheld (i.e. the combination of Tixagevimab and cilgavimab, AZD7742 or any other name that is used by the DHSC for this) is mentioned, whether by email or other electronic means.

Yours faithfully,

Louise Bicknell

Department of Health and Social Care

3 Attachments

Dear Ms Bicknell,

Please find attached the Department of Health and Social Care's response
to your recent FOI request (our ref: FOI-1429204).

Yours sincerely, 

Freedom of Information Team
Department of Health and Social Care

show quoted sections